Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

University of Kentucky

University of Kentucky in Lexington, Kentucky, United States is listed as a site for 780 registered clinical trials, 201 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 780
Ongoing 201

This page covers the site record University of Kentucky in Lexington, Kentucky, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, University of Kentucky, also sponsors trials.

Get the University of Kentucky report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 780 trials counted.

  • Phase 1 62 trials
  • Phase 1/2 24 trials
  • Phase 2 122 trials
  • Phase 2/3 12 trials
  • Phase 3 135 trials
  • Phase 4 29 trials
  • Not applicable 285 trials
  • Observational 110 trials
  • Expanded access 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 201 trials
  • Completed 472 trials
  • Terminated 94 trials
  • Other 13 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 72

1995: 1 trials (Phase 3 1) 1999: 2 trials (Observational 1, Phase 3 1) 2000: 1 trials (Phase 2 1) 2001: 2 trials (Phase 3 1, Phase 1/2 1) 2002: 1 trials (Phase 3 1) 2003: 9 trials (Observational 1, Not applicable 1, Phase 3 2, Phase 2 3, Phase 1/2 1, Phase 1 1) 2004: 13 trials (Observational 1, Not applicable 1, Phase 3 6, Phase 2 2, Phase 1 3) 2005: 23 trials (Observational 3, Not applicable 1, Phase 4 2, Phase 3 8, Phase 2/3 2, Phase 2 3, Phase 1/2 1, Phase 1 3) 2006: 16 trials (Observational 1, Not applicable 5, Phase 3 4, Phase 2 3, Phase 1 3) 2007: 17 trials (Observational 3, Not applicable 2, Phase 4 1, Phase 3 6, Phase 2 5) 2008: 19 trials (Observational 4, Not applicable 5, Phase 3 2, Phase 2 6, Phase 1/2 1, Phase 1 1) 2009: 26 trials (Observational 5, Not applicable 6, Phase 4 1, Phase 3 3, Phase 2/3 1, Phase 2 6, Phase 1 4) 2010: 18 trials (Observational 3, Not applicable 4, Phase 3 5, Phase 2/3 1, Phase 2 4, Phase 1/2 1) 2011: 22 trials (Observational 4, Not applicable 4, Phase 3 8, Phase 2 5, Phase 1 1) 2012: 18 trials (Observational 3, Not applicable 3, Phase 4 1, Phase 3 3, Phase 2 5, Phase 1/2 1, Phase 1 2) 2013: 21 trials (Observational 4, Not applicable 9, Phase 3 4, Phase 2 3, Phase 1/2 1) 2014: 20 trials (Observational 2, Not applicable 5, Phase 3 6, Phase 2/3 1, Phase 2 5, Phase 1 1) 2015: 41 trials (Observational 5, Not applicable 15, Phase 4 2, Phase 3 10, Phase 2 6, Phase 1 3) 2016: 26 trials (Observational 5, Not applicable 11, Phase 4 2, Phase 3 4, Phase 2 3, Phase 1 1) 2017: 41 trials (Observational 6, Not applicable 17, Phase 4 5, Phase 3 2, Phase 2/3 2, Phase 2 5, Phase 1/2 1, Phase 1 3) 2018: 41 trials (Observational 6, Not applicable 14, Phase 4 1, Phase 3 8, Phase 2/3 1, Phase 2 7, Phase 1/2 3, Phase 1 1) 2019: 54 trials (Observational 11, Not applicable 20, Phase 4 2, Phase 3 5, Phase 2 6, Phase 1/2 3, Phase 1 7) 2020: 50 trials (Observational 10, Not applicable 21, Phase 3 10, Phase 2/3 1, Phase 2 5, Phase 1/2 1, Phase 1 2) 2021: 72 trials (Observational 12, Not applicable 22, Phase 4 1, Phase 3 14, Phase 2/3 1, Phase 2 15, Phase 1/2 1, Phase 1 6) 2022: 50 trials (Observational 7, Not applicable 23, Phase 4 1, Phase 3 6, Phase 2 7, Phase 1/2 3, Phase 1 3) 2023: 45 trials (Observational 5, Not applicable 19, Phase 4 3, Phase 3 6, Phase 2 5, Phase 1/2 2, Phase 1 5) 2024: 43 trials (Observational 3, Not applicable 24, Phase 4 3, Phase 3 4, Phase 2/3 1, Phase 2 6, Phase 1 2) 2025: 50 trials (Observational 5, Not applicable 32, Phase 4 1, Phase 3 3, Phase 2 2, Phase 1/2 2, Phase 1 5)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 33
2025 50
2024 43
2023 45
2022 50
2021 72
2020 50
2019 54
2018 41
2017 41

Showing 10 of 29 years.

Start your 14-day trial Email me all 29 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 780 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 187 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 429 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF